DJO

DJO® Showcases Growing Foot & Ankle Portfolio at ACFAS Scientific Conference

Retrieved on: 
Martedì, Febbraio 22, 2022
Surgery, Medical Devices, Medical Supplies, Diabetes, Clinical Trials, Biotechnology, Other Health, Physical Therapy, Health, L-13 Light Industrial Workshop, Pain management, American College of Foot and Ankle Surgeons, American College, General manager, Innovation, Elective surgery, NYSE, Multimedia, CFX, Convention, Taiwan Oil Field Exhibition Hall, DJO, Conference, Colfax Corporation, ACFAS, Motion, Solution, New, Sports equipment, Medical imaging, Foot, Ankle

DJO, a subsidiary of Colfax Corporation (NYSE: CFX) and a leading global provider of medical technologies to get and keep people moving, today announced it will showcase their growing Foot & Ankle offerings at the 2022 American College of Foot and Ankle Surgeons (ACFAS) Scientific Conference in Austin from February 21-24, 2022.

Key Points: 
  • DJO, a subsidiary of Colfax Corporation (NYSE: CFX) and a leading global provider of medical technologies to get and keep people moving, today announced it will showcase their growing Foot & Ankle offerings at the 2022 American College of Foot and Ankle Surgeons (ACFAS) Scientific Conference in Austin from February 21-24, 2022.
  • DJO has created a dedicated foot and ankle business unit that expands the companys mission of Powering Motion.
  • (Photo: Business Wire)
    The last 14 months have been focused on building an intentional set of Foot & Ankle offerings through acquisitions and internal development here at DJO and now, we are ready to introduce ourselves as a Foot & Ankle division in one of the fastest growing markets of orthopedics, said Gary Justak, President and General Manager of DJOs Foot & Ankle Division.
  • We are here to provide disruptive innovation, share our proven outcomes and listen to the Foot & Ankle surgeon for continuous improvement and development opportunities.

Metallica, The Strokes, and Foo Fighters to Headline Boston Calling 2022

Retrieved on: 
Venerdì, Gennaio 21, 2022
Entertainment, Music, Events, Concerts, Entrepreneurship, Pom Pom Squad, King Gizzard & the Lizard Wizard, Love, Japanese Breakfast, Lord, Memorial Day, Foo Fighters, KennyHoopla, BCE, Peach Tree Rascals, Collection, HAIM, DJO, Rock, Boston Calling Music Festival, Oompas, EARTHGANG, GA, Seating assignment, Glass, Food, Sale, LLC, Friends, Platinum, Animal, VIP, Rock and Roll Hall of Fame, Sudan Archives, Nightclub, Stroke, Avenue, Metallica, Strut (disambiguation)

Headlining the festival are rock & roll icons Metallica; alternative rockers The Strokes, playing their first show in Boston since 2006; and Rock & Roll Hall of Famers Foo Fighters.

Key Points: 
  • Headlining the festival are rock & roll icons Metallica; alternative rockers The Strokes, playing their first show in Boston since 2006; and Rock & Roll Hall of Famers Foo Fighters.
  • We are so thrilled to bring Boston Calling back, and we cannot thank our loyal fans enough for supporting us as we navigated the pandemic.
  • Knowing how much Boston musicians endured during the pandemic, it was very important to us that Boston Calling 2022 shine a spotlight on local and regional artists more than ever before.
  • 2021 Rock & Roll Hall of Fame inductees and multi-GRAMMY Award winners Foo Fighters will headline the festival on Friday, May 27th.

Colfax Schedules Fourth Quarter and Fiscal Year 2021 Earnings Release and Conference Call

Retrieved on: 
Giovedì, Gennaio 20, 2022
ID, Webcast, GLOBE, Technology, NYSE, Intention, CFX, Wilmington, DE 2001, ESAB, International, Company, Colfax Corporation, DJO, Video game

Wilmington DE, Jan. 20, 2022 (GLOBE NEWSWIRE) -- Colfax Corporation (NYSE: CFX), a leading diversified technology company, today announced that it will issue a press release providing financial results for the fourth quarter and fiscal year 2021 on the morning of Tuesday, February 22, 2022. The Company will hold a conference call to discuss these results beginning at 8:00 a.m. Eastern on that day, which will be open to the public by calling +1-877-303-7908 (U.S. callers) and +1-678-373-0875 (International callers) and referencing the conference ID number 7466839 and through webcast via Colfax’s website www.colfaxcorp.com under the “Investors” section.

Key Points: 
  • Wilmington DE, Jan. 20, 2022 (GLOBE NEWSWIRE) -- Colfax Corporation (NYSE: CFX), a leading diversified technology company, today announced that it will issue a press release providing financial results for the fourth quarter and fiscal year 2021 on the morning of Tuesday, February 22, 2022.
  • Colfaxs financial results press release and supplemental information referenced on the call, if any, for the fourth quarter and fiscal year 2021 will be available under the Investors section of Colfaxs website prior to the conference call.
  • A link to a replay of the call will also be available on the Colfax website later that day.
  • The Company uses its Colfax Business System, a comprehensive set of tools and processes, to create superior value for customers, stockholders and associates.

Colfax to Present at the 40th Annual JP Morgan Healthcare Conference

Retrieved on: 
Lunedì, Gennaio 10, 2022
EST, ESAB, Conference, NYSE, Company, DJO, Intention, GLOBE, CFX, Technology, Pharmaceutical industry, Sales

Wilmington, DE, Jan. 10, 2022 (GLOBE NEWSWIRE) -- Colfax Corporation (NYSE: CFX), a leading diversified technology company, announced today that it will be presenting at the J.P. Morgan Healthcare Conference on January 12, at 3:00 pm (EST).  A live presentation of this event will be available via Colfax’s website at www.colfaxcorp.com under the “Investors” section. Replays will also be available on the Company’s website following the event.

Key Points: 
  • Wilmington, DE, Jan. 10, 2022 (GLOBE NEWSWIRE) -- Colfax Corporation (NYSE: CFX), a leading diversified technology company, announced today that it will be presenting at the J.P. Morgan Healthcare Conference on January 12, at3:00 pm (EST).
  • A live presentation of this event will be available via Colfaxs website at www.colfaxcorp.com under the Investors section.Replays will also be available on the Companys website following the event.
  • Colfax Corporation(NYSE: CFX) is a leading diversified technology company that provides orthopedic and fabrication technology products and services to customers around the world, principally under the DJO and ESAB brands.
  • The Company uses its Colfax Business System, a comprehensive set of tools and processes, to create superior value for customers, stockholders and associates.

Colfax Announces Plans for Reverse Stock Split

Retrieved on: 
Giovedì, Dicembre 30, 2021
COVID-19, ESAB, U.S. Securities and Exchange Commission, Communication, Board, Common stock, Internal Revenue Service, GLOBE, Company, Nature, Certificate, DJO, CFX, SEC, Prevalence, Annual report, F Street, NYSE, Review, Intention, Technology, Separation, Time, Director, Forward-looking statement, Certificate of incorporation, Security (finance), Holding company

WILMINGTON, DE, Dec. 30, 2021 (GLOBE NEWSWIRE) -- Colfax Corporation (“Colfax” or the “Company”) (NYSE: CFX), a leading diversified technology company, announced today that it plans to hold a special meeting of stockholders to seek approval for an amendment to the Company’s Amended and Restated Certificate of Incorporation (the “Certificate of Incorporation”) to effect, at the discretion of the Board of Directors, (i) a reverse stock split of the Company’s common stock, par value $0.001 per share (the “Common Stock”), at one of three reverse stock split ratios, one-for-two, one-for-three or one-for-four, with the exact ratio to be determined by the Board of Directors of the Company at a later date, and (ii) if and when the reverse stock split is effected, a corresponding reduction in the number of authorized shares of our Common Stock by the selected reverse stock split ratio.

Key Points: 
  • WILMINGTON, DE, Dec. 30, 2021 (GLOBE NEWSWIRE) -- Colfax Corporation (Colfax or the Company) (NYSE: CFX), a leading diversified technology company, announced today that it plans to hold a special meeting of stockholders to seek approval for an amendment to the Companys Amended and Restated Certificate of Incorporation (the Certificate of Incorporation) to effect, at the discretion of the Board of Directors, (i) a reverse stock split of the Companys common stock, par value $0.001 per share (the Common Stock), at one of three reverse stock split ratios, one-for-two, one-for-three or one-for-four, with the exact ratio to be determined by the Board of Directors of the Company at a later date, and (ii) if and when the reverse stock split is effected, a corresponding reduction in the number of authorized shares of our Common Stock by the selected reverse stock split ratio.
  • Colfax will hold a special meeting of stockholders on February 28, 2022 to seek approval of the reverse stock split and the corresponding authorized share count reduction.
  • Even if the reverse stock split proposal is approved by the Companys stockholders, the Board of Directors may delay or abandon the reverse stock split at any time prior to the effective time of the reverse stock split if the Board of Directors determines that the reverse stock split is no longer in the best interests of the Company or its stockholders.
  • In connection with the Reverse Split Proposal, Colfax plans to file a preliminary proxy statement on Schedule 14A with the SEC.

Advisory - Update: Expanded recall of medical devices manufactured by Eco-Med Pharmaceuticals due to potential contamination with Burkholderia stabilis

Retrieved on: 
Martedì, Dicembre 21, 2021
BCC, Burkholderia cepacia complex, Medicine, DJO, Health Canada, France, Medical device, Dietary supplement, Pharmaceutical industry

OTTAWA, ON, Dec. 20, 2021 /CNW/ - Medical devices manufactured by Eco-Med Pharmaceuticals, Inc. and being sold by DJO LLC and DJO France are being recalled voluntarily due to potential bacterial contamination with Burkholderia stabilis, a member of the Burkholderia cepacia complex (Bcc).

Key Points: 
  • OTTAWA, ON, Dec. 20, 2021 /CNW/ - Medical devices manufactured by Eco-Med Pharmaceuticals, Inc. and being sold by DJO LLC and DJO France are being recalled voluntarily due to potential bacterial contamination with Burkholderia stabilis, a member of the Burkholderia cepacia complex (Bcc).
  • Health Canada maintains a list of products manufactured by Eco-Med affected by this issue.
  • Please see the full advisory for more information, including what consumers should do.

Middle East & Africa Hip and Knee Reconstruction Devices Market Report 2021-2028 with Focus on Arthrodesis, Joint Replacement, Arthroscopy, Osteotomy, Resurfacing - ResearchAndMarkets.com

Retrieved on: 
Giovedì, Novembre 25, 2021
Surgery, Health, People, Man, Adoption, NCBI, Hip, CAGR, Awareness, Woman, Health, Prevalence, Pain management, Nature, COVID-19, Pain, Vaccination, Foot, Physician, Arthroscopy, Obesity, DJO, LLC, Incidence, Osteoarthritis, Medtronic, Growth, Joint, Medical device, Soft drink, Pharmaceutical industry

The "MEA Hip and Knee Reconstruction Devices Markets, 2021-2028" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "MEA Hip and Knee Reconstruction Devices Markets, 2021-2028" report has been added to ResearchAndMarkets.com's offering.
  • Physical inactivity due to sedentary lifestyle fueling obesity and lifestyle disorder prevalence are key drivers for the market.
  • It also stated that none to low-level physical activity was observed in 46% of men and 75.1% of women.
  • This can be attributed to the rise in adoption of telehealth platforms to consult physicians for various health issues, including pain arising from hip and knee disorders
    Chapter 3 Hip and Knee Reconstruction Devices Market Variables, Trends & Scope

Colfax Schedules Third Quarter 2021 Earnings Release and Conference Call

Retrieved on: 
Lunedì, Ottobre 18, 2021
NYSE, Webcast, International, ID, Technology, DJO, GLOBE, CFX, ESAB, Colfax Corporation, Intention, Company, Video game

WILMINGTON, DE, Oct. 18, 2021 (GLOBE NEWSWIRE) -- Colfax Corporation (NYSE: CFX), a leading diversified technology company, today announced that it will issue a press release providing financial results for the third quarter of 2021 on the morning of Thursday, November 4, 2021.

Key Points: 
  • WILMINGTON, DE, Oct. 18, 2021 (GLOBE NEWSWIRE) -- Colfax Corporation (NYSE: CFX), a leading diversified technology company, today announced that it will issue a press release providing financial results for the third quarter of 2021 on the morning of Thursday, November 4, 2021.
  • Colfaxs financial results press release and supplemental information referenced on the call, if any, for the third quarter of 2021 will be available under the Investors section of Colfaxs website prior to the conference call.
  • A link to a replay of the call will also be available on the Colfax website later that day.
  • The Company uses its Colfax Business System (CBS), a comprehensive set of tools and processes, to create superior value for customers, shareholders and associates.

DJO® Expands Active, Adaptive Healing Offerings with Introduction of MedShape® DynaNail Hybrid™

Retrieved on: 
Mercoledì, Settembre 22, 2021
Surgery, Medical Devices, Hospitals, Health, Managed Care, Colfax Corporation, Efficiency, Solution, Pain management, Duke University Hospital, Multimedia, Patient, Foot, Surgeon, Subtalar joint, Association, Evolution, Â, DJO, Company, General manager, NYSE, CFX, Medical imaging, Medical device

DJO, a subsidiary of Colfax Corporation (NYSE: CFX) and a leading global provider of medical technologies to get and keep people moving, today announced the launch of the MedShape DynaNail Hybrid Fusion System.

Key Points: 
  • DJO, a subsidiary of Colfax Corporation (NYSE: CFX) and a leading global provider of medical technologies to get and keep people moving, today announced the launch of the MedShape DynaNail Hybrid Fusion System.
  • View the full release here: https://www.businesswire.com/news/home/20210922005218/en/
    DJO MedShape DynaNail Hybrid Fusion System (Photo: Business Wire)
    Subtalar fusion surgery is often performed to correct severe foot deformity or relieve pain.
  • As its name suggests, the DynaNail Hybrid features a combined screw/nail design to provide todays surgeons with a winning balance of ease and reliability.
  • For more information on the DynaNail Hybrid and the entire DynaNail Mini family, please visit https://www.djoglobal.com/dynanail-hybrid .

Hot and Cold Therapy Packs Market Report 2021: Increasing Adoption of Non-pharmaceutical, Non-invasive Pain Management Therapies - Global Forecast to 2030 - ResearchAndMarkets.com

Retrieved on: 
Martedì, Settembre 14, 2021
Health, Other Health, Accident, Government, Incidence, Injury, Pain management, CAGR, Inflammation, Athlete, Cold, Growth, APAC, COVID-19, Pain, Prevalence, DJO, Dentistry

The "Hot and Cold Therapy Packs Market Research Report - Global Industry Analysis and Demand Forecast to 2030" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Hot and Cold Therapy Packs Market Research Report - Global Industry Analysis and Demand Forecast to 2030" report has been added to ResearchAndMarkets.com's offering.
  • Because of the COVID-19 pandemic, many manufacturing units of hot and cold therapy packs were either fully shut down or partially closed.
  • The hot and cold therapy packs market is classified into cold therapy packs and hot therapy packs, depending on type.
  • The players in the global hot and cold therapy packs market are focusing on launching products for gaining a significant edge over their rivals.